Sauar J, Stokke K T
Clin Chim Acta. 1979 Feb 15;92(1):101-5. doi: 10.1016/0009-8981(79)90402-9.
Hepatic lipase and lipoprotein lipase activity in postheparin plasma, plasma total estrogens (estradiol and estrone) and triglycerides were studied in patients with various liver disorders and in a reference group. The activity of hepatic lipase was not correlated to the estrogen level either in patients or in healthy controls. Peroral administration of estradiol valeriate to healthy females resulted, however, in a selective decline in hepatic lipase activity. A slight and not significant reduction was also observed in three infertile women after administration of follitropin (FSH) for a short period. The plasma concentration of estrogens did not correlate with the levels of plasma triglycerides and the relative content of triglycerides in low density lipoproteins either in patients or the controls. Lipase inhibition mediated by increase in estrogens therefore does not seem to exaplin the hypertriglyceridemia observed in patients with liver disease.
对患有各种肝脏疾病的患者以及一个参照组,研究了肝素后血浆中的肝脂酶和脂蛋白脂酶活性、血浆总雌激素(雌二醇和雌酮)以及甘油三酯。无论是患者还是健康对照者,肝脂酶活性均与雌激素水平无关。然而,对健康女性口服戊酸雌二醇会导致肝脂酶活性选择性下降。在三名不育女性短期注射促卵泡激素(FSH)后,也观察到了轻微且无显著意义的降低。无论是患者还是对照者,雌激素的血浆浓度均与血浆甘油三酯水平以及低密度脂蛋白中甘油三酯的相对含量无关。因此,雌激素增加介导的脂酶抑制似乎无法解释在肝病患者中观察到的高甘油三酯血症。